Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

06 February 2022: Clinical Research

Cognitive Dysfunction and Health-Related Quality of Life in Patients with End-Stage Renal Disease Undergoing Hemodialysis in Comparison with Patients Undergoing Peritoneal Dialysis: A Cross-Sectional Study

Bin Zeng 1ABCDEFG , Qiaoling Wang 1BCD , Shengkai Wu 1BCD , Sefen Lin 1BCD , Yanxian Li 1BCD , Wenying Jiang 1ABCDEFG , Ruifeng Guo 1BCD , Fenhui Zhou 1BCD , Kunzhe Lin 2AE*

DOI: 10.12659/MSM.934282

Med Sci Monit 2022; 28:e934282

Supplementary Table 1 Effects of hemodialysis and peritoneal dialysis on cognition dysfunction and HRQOL.

MeasureVariableβS.EtP95% CI
LowerUpper
MoCAMODEL1
 Intercept32.421.2526.0429.9634.87
 Dialysis modality (Peritoneal dialysis vs Hemodialysis)−8.350.76−11.02−9.85−6.86
MODEL2
 Intercept43.041.9921.6139.1246.97
 Gender (female vs male)−1.710.72−2.360.019−3.13−0.28
 Age−0.180.03−5.96−0.23−0.12
 Dialysis modality (peritoneal dialysis vs hemodialysis)−7.160.74−9.71−8.61−5.70
MODEL3
 Intercept33.734.307.8525.2642.19
 Gender (female vs male)−1.250.71−1.760.080−2.650.15
 Age, years−0.130.04−3.210.002−0.20−0.05
 BMI0.240.121.920.055−0.010.48
 Marital status (unmarried vs married)−1.491.50−0.990.321−4.441.46
 Educational level2.480.554.471.393.57
 Income level−0.020.65−0.030.974−1.301.26
 Diabetes (yes)−1.110.78−1.430.155−2.640.42
 Duration of kidney disease, years−0.150.09−1.750.081−0.330.02
 Duration of dialysis, months0.010.020.640.520−0.020.05
 Dialysis frequency, weeks0.111.050.110.916−1.962.18
 Dialysis modality (peritoneal dialysis vs hemodialysis)−7.020.89−7.85−8.78−5.26
SF-36MODEL1
 Intercept37.401.4625.6934.5340.27
 Dialysis modality (peritoneal dialysis vs hemodialysis)−10.200.89−11.50−11.94−8.45
MODEL2
 Intercept48.452.3720.4843.8053.11
 Gender (female vs male)−1.400.86−1.630.104−3.090.29
 Age, years−0.190.04−5.47−0.26−0.12
 Dialysis modality (peritoneal dialysis vs hemodialysis)−9.000.88−10.29−10.73−7.28
MODEL3
 Intercept41.575.108.1531.5351.61
 Gender (female vs male)−0.970.84−1.150.251−2.630.69
 Age, years−0.120.05−2.460.015−0.21−0.02
 BMI0.310.152.130.0340.020.60
 Marital status (unmarried vs married)−1.741.78−0.980.330−5.241.77
 Educational level1.800.662.740.0070.513.09
 Income level−0.910.77−1.170.242−2.430.61
 Diabetes (yes)−2.760.92−2.990.003−4.57−0.94
 Duration of kidney disease, years−0.270.11−2.620.009−0.48−0.07
 Duration of dialysis, months−0.050.02−2.130.034−0.09−0.00
 Dialysis frequency, weeks0.661.250.530.597−1.793.11
 Dialysis modality (peritoneal dialysis vs hemodialysis)−8.671.06−8.17−10.76−6.58
KDTAMODEL1
 Intercept38.191.2031.9235.8340.54
 Dialysis modality (peritoneal dialysis vs hemodialysis)−8.670.73−11.90−10.10−7.23
MODEL2
 Intercept47.681.9324.6843.8851.49
 Gender (female vs male)−1.210.70−1.720.087−2.590.18
 Age, years−0.160.03−5.75−0.22−0.11
 Dialysis modality (peritoneal dialysis vs hemodialysis)−7.640.72−10.70−9.05−6.24
MODEL3
 Intercept40.624.159.8032.4548.78
 Gender (female vs male)−0.880.68−1.290.199−2.230.47
 Age, years−0.100.04−2.680.008−0.18−0.03
 BMI0.230.121.890.060−0.010.46
 Marital status (unmarried vs married)−1.151.45−0.790.428−4.001.70
 Educational level1.730.543.240.0010.682.79
 Income level−0.420.63−0.660.509−1.650.82
 Diabetes (yes)−1.790.75−2.390.017−3.27−0.32
 Duration of kidney disease, years−0.230.09−2.670.008−0.39−0.06
 Duration of dialysis, months−0.040.02−2.450.015−0.08−0.01
 Dialysis frequency, weeks1.111.011.090.276−0.893.10
 Dialysis modality (peritoneal dialysis vs hemodialysis)−7.550.86−8.75−9.25−5.85
CI – confidential interval; BMI – body mass index; MoCA – Montreal Cognitive Assessment; SF-36 – Short Form-36; KDTA – kidney disease-related quality of life assessment. Model 1 – the univariate linear regression; Model 2 – gender and age were adjusted; Model 3 – gender, age, BMI, marital status, education level, income level, presence of diabetes, duration of kidney disease, duration of dialysis, and dialysis frequency were adjusted.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750